b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30723749</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>04</Month>\n            <Day>22</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>25</Day>\n        </DateRevised>\n        <Article PubModel="Electronic-eCollection">\n            <Journal>\n                <ISSN IssnType="Electronic">2314-7156</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>2019</Volume>\n                    <PubDate>\n                        <Year>2019</Year>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of immunology research</Title>\n                <ISOAbbreviation>J Immunol Res</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle><i>KIR/HLA</i> Gene Profile Implication in Systemic Sclerosis Patients from Mexico.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>6808061</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2019/6808061</ELocationID>\n            <Abstract>\n                <AbstractText Label="Introduction" NlmCategory="UNASSIGNED">Systemic Sclerosis (SSc) is an autoimmune, inflammatory, and multisystemic disease characterized by the presence of autoantibodies and fibrosis. The pathogenesis involves the interaction between immune system cells such as macrophages, NK cells, T cells, and B cells. Killer-cell Immunoglobulin-like Receptors (KIR) are expressed in NK cells and some T cell subsets that recognize HLA class I molecules as ligands and are involved in regulating the activation and inhibition of these cells. The <i>KIR</i> family consists of 14 genes and two pseudogenes; according to the gene content, the genotype could be AA and Bx. The aim of this study was to evaluate the association between <i>KIR/HLA</i> genes and genotypes with SSc and the clinical characteristics.</AbstractText>\n                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">We included 50 SSc patients and 90 Control Subjects (CS). Genotyping of <i>KIR</i>, <i>HLA-C</i>, <i>-Bw4</i>, and <i>-A</i><sup>\xe2\x88\x97</sup><i>03/</i><sup>\xe2\x88\x97</sup><i>11</i> was made by SSP-PCR.</AbstractText>\n                <AbstractText Label="Results" NlmCategory="UNASSIGNED">In SSc patients, a higher frequency of <i>KIR2DL2</i> (<i>p</i> = 0.0007, <i>p</i>\' = 0.011), <i>KIR2DS4del</i> (<i>p</i> = 0.001, <i>p</i>\' = 0.021), and <i>HLA-C2</i> (<i>p</i> = 0.02, <i>p</i>\' = 0.09) was found. This is the first study to evaluate the frequency of <i>HLA-A</i><sup>\xe2\x88\x97</sup><i>03/</i><sup>\xe2\x88\x97</sup><i>11</i> in SSc patients, of which a low frequency was found in both groups. Compound genotypes <i>KIR2DL2+/HLA-C1+</i> or <i>KIR2DL2+/HLA-C2+</i> have a higher frequency in SSc patients. The Bx genotype was the most frequent and was associated with risk to SSc (<i>p</i> = 0.007, OR = 3.1, 95% CI = 1.4-7.9, <i>p</i>\' = 0.014). The genotypes with a higher <i>iKIR</i> number than <i>aKIR</i> (<i>iKIR</i> &gt; <i>aKIR</i>) were found in all individuals; genotypes with 7-8 <i>iKIR</i> genes were increased in SSc patients. We do not find an association between the <i>KIR</i> genes with the clinical characteristics.</AbstractText>\n                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">The results suggest that <i>KIR2DL2</i> and <i>2DS4del</i> could have a risk role in the development of SSc, but not with clinical manifestations.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Machado-Sulbaran</LastName>\n                    <ForeName>Andrea Carolina</ForeName>\n                    <Initials>AC</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Universidad de Guadalajara, Laboratorio de Inmunolog\xc3\xada, Departamento de Fisiolog\xc3\xada, Centro Universitario de Ciencias de la Salud, 44340 Guadalajara, Jalisco, Mexico.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ram\xc3\xadrez-Due\xc3\xb1as</LastName>\n                    <ForeName>Mar\xc3\xada Guadalupe</ForeName>\n                    <Initials>MG</Initials>\n                    <Identifier Source="ORCID">0000-0001-8066-5966</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Universidad de Guadalajara, Laboratorio de Inmunolog\xc3\xada, Departamento de Fisiolog\xc3\xada, Centro Universitario de Ciencias de la Salud, 44340 Guadalajara, Jalisco, Mexico.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Navarro-Zarza</LastName>\n                    <ForeName>Jos\xc3\xa9 Eduardo</ForeName>\n                    <Initials>JE</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Hospital General Dr. Raymundo Abarca Alarc\xc3\xb3n, Departamento de Medicina Interna-Reumatolog\xc3\xada, 39019 Chilpancingo, Guerrero, Mexico.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mu\xc3\xb1oz-Valle</LastName>\n                    <ForeName>Jos\xc3\xa9 Francisco</ForeName>\n                    <Initials>JF</Initials>\n                    <Identifier Source="ORCID">0000-0002-2272-9260</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Universidad de Guadalajara, Instituto de Investigaci\xc3\xb3n en Ciencias Biom\xc3\xa9dicas, Departamento de Biolog\xc3\xada Molecular y Gen\xc3\xb3mica, 44340 Guadalajara, Jalisco, Mexico.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mendoza-Carrera</LastName>\n                    <ForeName>Francisco</ForeName>\n                    <Initials>F</Initials>\n                    <Identifier Source="ORCID">0000-0002-0786-988X</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Instituto Mexicano del Seguro Social, Divisi\xc3\xb3n de Medicina Molecular, Centro de Investigaci\xc3\xb3n Biom\xc3\xa9dica de Occidente, 44340 Guadalajara, Jalisco, Mexico.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ba\xc3\xb1os-Hern\xc3\xa1ndez</LastName>\n                    <ForeName>Christian Johana</ForeName>\n                    <Initials>CJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Universidad Aut\xc3\xb3noma de Guerrero, Laboratorio de Investigaci\xc3\xb3n de Obesidad y Diabetes, Facultad de Ciencias Qu\xc3\xadmico Biol\xc3\xb3gicas, 39090 Chilpancingo, Guerrero, Mexico.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Parra-Rojas</LastName>\n                    <ForeName>Isela</ForeName>\n                    <Initials>I</Initials>\n                    <Identifier Source="ORCID">0000-0002-9213-8263</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Universidad Aut\xc3\xb3noma de Guerrero, Laboratorio de Investigaci\xc3\xb3n de Obesidad y Diabetes, Facultad de Ciencias Qu\xc3\xadmico Biol\xc3\xb3gicas, 39090 Chilpancingo, Guerrero, Mexico.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Montoya-Buelna</LastName>\n                    <ForeName>Margarita</ForeName>\n                    <Initials>M</Initials>\n                    <Identifier Source="ORCID">0000-0001-9309-1957</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Universidad de Guadalajara, Laboratorio de Inmunolog\xc3\xada, Departamento de Fisiolog\xc3\xada, Centro Universitario de Ciencias de la Salud, 44340 Guadalajara, Jalisco, Mexico.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>S\xc3\xa1nchez-Hern\xc3\xa1ndez</LastName>\n                    <ForeName>Pedro Ernesto</ForeName>\n                    <Initials>PE</Initials>\n                    <Identifier Source="ORCID">0000-0001-5047-8115</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Universidad de Guadalajara, Laboratorio de Inmunolog\xc3\xada, Departamento de Fisiolog\xc3\xada, Centro Universitario de Ciencias de la Salud, 44340 Guadalajara, Jalisco, Mexico.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>01</Month>\n                <Day>06</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Egypt</Country>\n            <MedlineTA>J Immunol Res</MedlineTA>\n            <NlmUniqueID>101627166</NlmUniqueID>\n            <ISSNLinking>2314-7156</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D054340">Receptors, KIR</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005787" MajorTopicYN="Y">Gene Frequency</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005805" MajorTopicYN="Y">Genes, MHC Class I</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005838" MajorTopicYN="Y">Genotype</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D060005" MajorTopicYN="N">Genotyping Techniques</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008800" MajorTopicYN="N" Type="Geographic">Mexico</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D054340" MajorTopicYN="N">Receptors, KIR</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012595" MajorTopicYN="N">Scleroderma, Systemic</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>08</Month>\n                <Day>27</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>01</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>15</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>2</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>2</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>4</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30723749</ArticleId>\n            <ArticleId IdType="doi">10.1155/2019/6808061</ArticleId>\n            <ArticleId IdType="pmc">PMC6339729</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Tissue Antigens. 1999 Jan;53(1):81-96</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10082434</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Toxicology. 2000 Sep 7;150(1-3):147-57</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10996671</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Immunol Rev. 2002 Dec;190:40-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12493005</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arthritis Rheum. 2004 May;50(5):1561-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15146426</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Invest Dermatol. 2005 Oct;125(4):731-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16185273</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Hum Immunol. 2007 Feb;68(2):128-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17321903</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Tissue Antigens. 2007 Apr;69 Suppl 1:106-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17445179</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Tissue Antigens. 2007 Nov;70(5):415-22</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17854430</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mol Immunol. 2008 Feb;45(4):1171-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17904223</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Hum Reprod. 2008 Apr;23(4):972-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18263639</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Immunogenetics. 2008 Dec;60(12):711-25</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18797862</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Genome Res. 2009 May;19(5):757-69</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19411600</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Immunogenet. 2010 Jun;37(3):159-68</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20193031</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Immunogenetics. 2010 Dec;62(11-12):729-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20878401</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Immunogenet. 2012 Apr;39(2):114-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22128817</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Autoimmun. 2012 Sep;39(3):206-15</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22704425</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neuroimmunol. 2012 Oct 15;251(1-2):55-64</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22871633</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2012;7(9):e44718</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23028591</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Front Immunol. 2013 Jan 29;4:8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23372569</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Rev Bras Reumatol. 2013 Feb;53(1):66-74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23588517</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2013 Jun 6;121(23):4703-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23637128</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Dis Markers. 2013;35(2):73-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24167351</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2014 Mar 13;9(3):e88455</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24625755</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Front Immunol. 2014 Apr 22;5:184</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24795726</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Environ Mol Mutagen. 2014 Oct;55(8):652-61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24889798</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMC Musculoskelet Disord. 2014 Jul 28;15:256</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25069714</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nucleic Acids Res. 2015 Jan;43(Database issue):D784-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25414323</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Bronconeumol. 2015 Jun;51(6):285-92</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25614376</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2015 May 20;10(5):e0126727</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25993664</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Hum Genet. 2015 Sep;134(9):929-40</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26099314</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Inflamm (Lond). 2015 Jul 30;12:48</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26225124</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Rev Allergy Immunol. 2015 Dec;49(3):347-69</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26445774</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biol Blood Marrow Transplant. 2016 Feb;22(2):220-225</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26476204</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Environ Res. 2016 Apr;146:85-91</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26724462</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Autoimmun Rev. 2016 May;15(5):417-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26802722</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Rheumatol. 2016 Apr;35(4):919-25</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26960450</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Genet Mol Biol. 2016 Mar;39(1):14-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27007893</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Dis Primers. 2015 Apr 23;1:15002</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27189141</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Immunopharmacol Immunotoxicol. 2016 Aug;38(4):303-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27251940</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Rheumatol. 2017 Apr;36(4):853-862</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28120169</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Autoimmun. 2017 Sep;83:22-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28285736</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Hum Immunol. 2017 Oct;78(10):614-620</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28734803</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Rheumatol. 2018 Jul;37(7):1977-1982</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29476353</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nucleic Acids Res. 1988 Feb 11;16(3):1215</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">3344216</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Control Clin Trials. 1998 Dec;19(6):589-601</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9875838</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'